NO20035683D0 - Optisk avbildning av prostatakreft - Google Patents
Optisk avbildning av prostatakreftInfo
- Publication number
- NO20035683D0 NO20035683D0 NO20035683A NO20035683A NO20035683D0 NO 20035683 D0 NO20035683 D0 NO 20035683D0 NO 20035683 A NO20035683 A NO 20035683A NO 20035683 A NO20035683 A NO 20035683A NO 20035683 D0 NO20035683 D0 NO 20035683D0
- Authority
- NO
- Norway
- Prior art keywords
- prostate cancer
- optical imaging
- imaging
- optical
- prostate
- Prior art date
Links
- 206010060862 Prostate cancer Diseases 0.000 title 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 title 1
- 238000012634 optical imaging Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0056—Peptides, proteins, polyamino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
- A61K49/0043—Fluorescein, used in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0052—Small organic molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO20035683A NO20035683D0 (no) | 2003-12-18 | 2003-12-18 | Optisk avbildning av prostatakreft |
PCT/NO2004/000394 WO2005058372A1 (en) | 2003-12-18 | 2004-12-17 | Optical imaging contrast agents for imaging lung cancer |
US10/582,842 US20080044350A1 (en) | 2003-12-18 | 2004-12-17 | Optical Imaging Contrast Agents for Imaging Lung Cancer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO20035683A NO20035683D0 (no) | 2003-12-18 | 2003-12-18 | Optisk avbildning av prostatakreft |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20035683D0 true NO20035683D0 (no) | 2003-12-18 |
Family
ID=31885173
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20035683A NO20035683D0 (no) | 2003-12-18 | 2003-12-18 | Optisk avbildning av prostatakreft |
Country Status (3)
Country | Link |
---|---|
US (1) | US20080044350A1 (no) |
NO (1) | NO20035683D0 (no) |
WO (1) | WO2005058372A1 (no) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7597878B2 (en) | 2000-09-19 | 2009-10-06 | Li-Cor, Inc. | Optical fluorescent imaging |
JP2010507645A (ja) * | 2006-10-25 | 2010-03-11 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 前立腺癌を検出するための造影剤 |
CA2678717A1 (en) | 2007-02-28 | 2008-09-04 | Sanofi-Aventis | Imaging probes |
DE102007028659A1 (de) * | 2007-06-21 | 2008-12-24 | Siemens Ag | Diagnosesubstanz und Verfahren zur Diagnose von Prostataerkrankungen |
DE102007037008B4 (de) * | 2007-08-06 | 2015-09-10 | Siemens Aktiengesellschaft | Diagnosesubstanz zur Anwendung in einem Verfahren zur Bestimmung der Aggressivität eines Prostatatumors |
US20100104513A1 (en) * | 2008-10-28 | 2010-04-29 | General Electric Company | Method and system for dye assessment |
CA2745961A1 (en) * | 2008-12-04 | 2010-06-10 | The Regents Of The University Of California | Materials and methods for determining diagnosis and prognosis of prostate cancer |
WO2010076334A2 (en) * | 2008-12-31 | 2010-07-08 | Centre Leon Berard | Intraoperative diagnosis of primary tumors and secondary tumors or metastases |
DE102010010666A1 (de) * | 2010-03-01 | 2011-09-01 | Sven Reske | Diagnose und Therapie von Krebserkrankungen mittels Fettsäuren |
WO2013070688A1 (en) | 2011-11-11 | 2013-05-16 | Yale University | Reprogramming urokinase into an antibody-recruiting anticancer agent |
ES2828954T3 (es) | 2014-09-17 | 2021-05-28 | Fluoguide As | Péptido de localización específica de uPAR para su uso en la formación peroperatoria de imágenes ópticas de cáncer invasivo |
CN111393503B (zh) * | 2019-01-03 | 2022-05-13 | 北京京东方技术开发有限公司 | 一种类肽及其制备方法和用途 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1093768C (zh) * | 1995-01-30 | 2002-11-06 | 第一化学药品株式会社 | 诊断用标记物 |
NZ331629A (en) * | 1996-04-01 | 2000-04-28 | Epix Medical Inc | Bioactivated diagnostic imaging contrast agents |
ES2257771T3 (es) * | 1996-10-28 | 2006-08-01 | Amersham Health As | Agentes de contraste. |
GB9708265D0 (en) * | 1997-04-24 | 1997-06-18 | Nycomed Imaging As | Contrast agents |
US6083486A (en) * | 1998-05-14 | 2000-07-04 | The General Hospital Corporation | Intramolecularly-quenched near infrared fluorescent probes |
US6652836B2 (en) * | 1998-10-15 | 2003-11-25 | Fluoroprobe, Inc. | Method for viewing tumor tissue located within a body cavity |
DE19917713A1 (de) * | 1999-04-09 | 2000-10-19 | Diagnostikforschung Inst | Kurzkettige Peptid-Farbstoffkonjugate als Konstrastmittel für die optische Diagnostik |
ATE350661T1 (de) * | 1999-04-13 | 2007-01-15 | Wilex Ag | Diagnostischer und therapeutischer einsatz von antikörpern gegen den urokinase-rezeptor |
US6217848B1 (en) * | 1999-05-20 | 2001-04-17 | Mallinckrodt Inc. | Cyanine and indocyanine dye bioconjugates for biomedical applications |
US7790144B2 (en) * | 2000-01-18 | 2010-09-07 | Mallinckrodt Inc. | Receptor-avid exogenous optical contrast and therapeutic agents |
WO2001089584A2 (en) * | 2000-05-23 | 2001-11-29 | Amersham Health As | Contrast agents |
JP5078212B2 (ja) * | 2000-06-02 | 2012-11-21 | ブラッコ・スイス・ソシエテ・アノニム | 内皮細胞を標的とするための化合物、それを含む組成物およびその使用方法 |
DE60137335D1 (de) * | 2000-08-07 | 2009-02-26 | Univ Vanderbilt | Nachweis der COX-2 Aktivität und von Anandamid-Metaboliten |
US20030044353A1 (en) * | 2001-01-05 | 2003-03-06 | Ralph Weissleder | Activatable imaging probes |
US6562319B2 (en) * | 2001-03-12 | 2003-05-13 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy |
WO2003074450A2 (en) * | 2002-02-28 | 2003-09-12 | The University Of Tennessee Research Corporation | Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy |
AU2004253159A1 (en) * | 2003-06-25 | 2005-01-06 | Vanderbilt University | COX-2-targeted imaging agents |
NO20033115D0 (no) * | 2003-07-08 | 2003-07-08 | Amersham Health As | Peptid-baserte forbindelser |
US7371364B2 (en) * | 2003-08-15 | 2008-05-13 | Board Of Regents, The University Of Texas System | Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy |
NO20034350D0 (no) * | 2003-09-29 | 2003-09-29 | Amersham Health As | Optisk avbilding av kolorektal kreft |
-
2003
- 2003-12-18 NO NO20035683A patent/NO20035683D0/no unknown
-
2004
- 2004-12-17 WO PCT/NO2004/000394 patent/WO2005058372A1/en active Application Filing
- 2004-12-17 US US10/582,842 patent/US20080044350A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20080044350A1 (en) | 2008-02-21 |
WO2005058372A1 (en) | 2005-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS8125A (is) | Kínasólínafleiður til að meðhöndla krabbamein | |
DK3470535T3 (da) | Forudsigelse af sandsynlighed for tilbagevenden af cancer | |
DK1948180T3 (da) | Kombinationsbehandling af cancer omfattende EGFR/HER2 inhibitorer | |
FI20030326A0 (fi) | Datan syöttö | |
NO20053782D0 (no) | Behandling av kreft med 2-deoksyglukose | |
DE602004019373D1 (de) | Bilderzeugungsverfahren | |
NL1029763A1 (nl) | Bereiding van gesubstitueerde chinazolinen. | |
DE112005003698A5 (de) | Erfassung optischer Strahlung | |
DK1660041T3 (da) | Ikke-polær fotosensibilisator til fotodynamisk terapi | |
DE602004017558D1 (de) | Endoskop mit ultravioletter Bestrahlung | |
NO20035681D0 (no) | Optisk avbildning av lungekreft | |
DK1587837T3 (da) | Epitopsekvenser til diagnose og behandling af prostatacancer | |
DK1499730T3 (da) | Immunokonjugater til behandling af tumorer | |
DE602004030576D1 (de) | Optisches aufzeichnungsverfahren | |
NO20054188D0 (no) | Et arrangement av fagverksstag | |
NO20035683D0 (no) | Optisk avbildning av prostatakreft | |
DK1589678T3 (da) | Optisk antenne | |
DE602004026172D1 (de) | Optischer detektor der enzymaktivierung | |
NO20034350D0 (no) | Optisk avbilding av kolorektal kreft | |
DE602004019259D1 (de) | Optischer Kollimator | |
DE602004005803D1 (de) | Zweidimensionaler optischer Ablenker | |
NO20055449D0 (no) | Fremgangsmate for diagnostisering av behandling av kreft | |
NO20063114L (no) | Enoxaparin for behandling av cancer | |
DE602004000502D1 (de) | Optischer Breitbandverstärker | |
DE10347306B4 (de) | Schirmanbindung |